Mr. Speaker, it is very hard to say that the changes to the patent drug regulations were rushed through. They were pre-published back in January. There was a public consultation period that lasted 30 days and ended on February 23. We heard submissions from all sides. The changes were put before the special committee of council in the normal course for regulations last week and then were signed and proclaimed after they were passed. There were no surprises here.
What we have done is achieve an appropriate balance between the interests of the two sectors of this industry.